825
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comparison of golimumab 100-mg monotherapy to golimumab 50 mg plus methotrexate in patients with rheumatoid arthritis: Results from a multicenter, cohort study

, , , , , , , , , , & show all
Pages 24-28 | Received 13 Apr 2014, Accepted 09 Jun 2015, Published online: 03 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Takahito Suto, Yukio Yonemoto, Koichi Okamura, Hideo Sakane, Kimihiko Takeuchi, Yasuyuki Tamura, Tetsuya Kaneko, Keio Ayabe & Hirotaka Chikuda. (2019) The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis. Modern Rheumatology 29:5, pages 775-781.
Read now
Rie Suematsu, Satoko Tashiro, Nobuyuki Ono, Syuichi Koarada, Akihide Ohta & Yoshifumi Tada. (2018) Successful golimumab therapy in four patients with refractory Takayasu’s arteritis. Modern Rheumatology 28:4, pages 712-715.
Read now
Ayaka Yoshikawa, Shuzo Yoshida, Yuko Kimura, Nao Tokai, Yohei Fujiki, Takuya Kotani, Yoko Matsumura, Tohru Takeuchi & Shigeki Makino. (2018) Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study. Modern Rheumatology 28:2, pages 227-234.
Read now

Articles from other publishers (2)

Yoichi Kurosawa, Satoshi Ito, Shunsuke Sakai, Eriko Hasegawa, Daisuke Kobayashi, Asami Abe, Hiroshi Otani, Kiyoshi Nakazono, Akira Murasawa, Ichiei Narita & Hajime Ishikawa. (2022) Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis. Internal Medicine 61:14, pages 2117-2125.
Crossref
Tsuyoshi TAKEDA. (2016) Treatment strategy of elderly rheumatoid arthritis. Japanese Journal of Clinical Immunology 39:6, pages 497-504.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.